ACTN2 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, it was previously reported that IRES translation could lead to the expression of a novel protein, MPD6, in cancer cells (prostate cancer, chronic myelogenous leukemia) distinct from that coded by the main ORF (myotrophin) and generate a strong immune response [24].